Faheem Tahir

Contributing Author

Recent Articles by Faheem Tahir

Dec-25	Analysts Confident in Harmonic (HLIT) Outlook As Video Business Divestiture Advances HLIT Insider Monkey
Dec-25	Entegris (ENTG) Management Confident in Future Growth Despite Bearish Sentiment from Goldman Sachs ENTG Insider Monkey
Dec-25	Uber and Lyft Partner With Baidu (BIDU) to Launch Driverless Taxi Trials in the UK BIDU Insider Monkey
Dec-25	Wells Fargo Bullish on Synaptics (SYNA) Due to Attractive Risk/Reward Profile SYNA Insider Monkey
Dec-25	Analyst Sentiment Positive on PDF Solutions (PDFS) Amid Strong Future Outlook PDFS Insider Monkey
Dec-25	Pegasystems (PEGA) Advances Agentic AI in Compliance Software Amid Intensifying Regulatory Demand PEGA Insider Monkey
Dec-25	Analysts Confident in NXP Semiconductors (NXPI) Amid Improving Outlook on Diversified Analog Semiconductor Market NXPI Insider Monkey
Dec-25	Analysts Confident in NXP Semiconductors (NXPI) Amid Improving Outlook on Diversified Analog Semiconductor Market NXPI Insider Monkey
Dec-21	Bullish Analyst Sentiment on Fulcrum Therapeutics (FULC) Following Positive Updates from Phase 1b PIONEER Study FULC Insider Monkey
Dec-21	Taysha Gene (TSHA) Hovers Around Its 52-Week High As It Continues to Advance Rett Syndrome Program TSHA Insider Monkey
Dec-21	High Analyst Confidence on Palvella Therapeutics (PVLA) Following Encouraging Phase 2 Data for QTORIN Rapamycin PVLA Insider Monkey
Dec-21	Gossamer Bio (GOSS) Sees Strong Analyst Confidence Amid Seralutinib Progress and Upcoming PROSERA Data GOSS Insider Monkey
Dec-21	Strong REZOLVE-AA Study Results Drive Analyst Confidence in Nektar Therapeutics (NKTR) NKTR Insider Monkey
Dec-21	Trevi Therapeutics (TRVI) Targets Next Phase of Growth with Leadership Change TRVI Insider Monkey
Dec-21	Analysts Remain Bullish on Seabridge Gold (SA) Amid KSM Project Progress SA Insider Monkey
Dec-21	TD Cowen Initiates Coverage on RAPT Therapeutics (RAPT) with a "Buy" RAPT Insider Monkey
Dec-21	Analysts Bullish as Ventyx Biosciences (VTYX) Advances Its Clinical and Strategic Initiatives VTYX Insider Monkey
Dec-21	Analyst Sentiment Remains Bullish on CytomX Therapeutics (CTMX) Amid CX-2051 Therapy Progress CTMX Insider Monkey
Dec-21	H.C Wainwright and Citizens Raise PT on DBV Technologies (DBVT) Following Phase 3 VITESSE Trial Result DBVT Insider Monkey
Dec-21	Compass Therapeutics' (CMPX) Tovecimig Drives Strong Analyst Sentiment CMPX Insider Monkey
Dec-17	Stifel Bullish on Equinox Gold (EQX) As Valentine Progress Accelerates EQX Insider Monkey
Dec-17	Orla Mining (ORLA) Lifts Investor Sentiment With Shares Near All-Time Highs ORLA Insider Monkey
Dec-17	Kinross Gold Corporation (KGC) Shares Trade Near 52-Week High Amid Jefferies Target Hike KGC Insider Monkey
Dec-17	Coeur Mining (CDE) May Be Fully Valued After Strong 2025 Rally CDE Insider Monkey
Dec-17	B2Gold (BTG) Draws Analyst Interest for High Gold-Price Leverage BTG Insider Monkey
Dec-17	New Gold (NGD) Trades Near 52-Week Following Strong Share Price Surge in 2025 NGD Insider Monkey
Dec-17	IAMGOLD (IAG) Trades Near Its 52-Week Amid Strong Share Price Surge in 2025 IAG Insider Monkey
Dec-17	Newmont (NEM) Climbs to All-Time High Amid Strong Gold Momentum NEM Insider Monkey
Dec-17	Barrick Mining (B) Trades Near Its 52-Week Amid Strong Share Price Surge in 2025 B Insider Monkey
Dec-17	Sibanye Stillwater (SBSW) Builds Momentum as Debt Declines and Palladium Outlook Improves SBSW Insider Monkey
Dec-11	Strong Momentum in Block (XYZ)'s Square and Cash App Segments Drives UBS' Bullish Stance XYZ Insider Monkey
Dec-11	Nebius Group N.V. (NBIS) Co-Founder Sees Huge AI Demand Ahead Backed by Mega Microsoft, Meta Deals NBIS Insider Monkey
Dec-11	Bullish Analyst Sentiment on Wix.com (WIX) Despite CFRA's Lowered Target and Slower Growth Outlook WIX Insider Monkey
Dec-11	Datadog (DDOG) Sees Bullish Analyst Stance Amid Strong AI and Observability Momentum Despite Recent Stock Pullback DDOG Insider Monkey
Dec-11	Intuit (INTU) Sees Positive Analyst Sentiment Following Strong Fiscal Q1 2026 Results INTU Insider Monkey
Dec-11	ServiceNow (NOW) Deepens Its Long-Term Commitment to Canada with CA$110 Million Investment; Analysts Remain Bullish NOW Insider Monkey
Dec-11	Bullish Analyst Sentiment on Salesforce (CRM) Amid Expanding Enterprise Demand and Strong Q3 Results CRM Insider Monkey
Dec-11	U.S. Approves NVIDIA's (NVDA) H200 Processor Exports to China, CEO Flags China's AI Infrastructure Advantage NVDA Insider Monkey
Dec-11	Bullish Analyst Sentiment on Meta Platforms (META) Amid AI Wearables Acquisition and Next-Generation Hardware Plans META Insider Monkey
Dec-11	Guggenheim Initiates Coverage of Amazon.com (AMZN) with "Buy" Rating and $300 Price Target AMZN Insider Monkey
Dec-11	Arista Networks (ANET) Eyes AI, Data-Center Expansion as Rosenblatt Stays Neutral ANET Insider Monkey
Dec-11	DA Davidson Remains Cautious on Workday (WDAY) Amid Market Saturation and Intensifying Competition WDAY Insider Monkey
Dec-11	Microsoft (MSFT) Announces $23 Billion Investment Plan, Morgan Stanley Reiterates "Buy" Rating MSFT Insider Monkey
Dec-10	Mizuho Securities Reiterates Buy Rating on Adobe (ADBE) Ahead of Q4 Results With $450 PT ADBE Insider Monkey
Dec-10	Bernstein Reiterates "Buy" Rating on Oracle Corporation (ORCL) with $364 PT ORCL Insider Monkey
Dec-01	Strong Analyst Confidence in Compass Therapeutics (CMPX) Driven by CTX-10726 Advancement CMPX Insider Monkey
Nov-30	Strong Operational Performance Steers Analyst Confidence in Nutanix (NTNX) NTNX Insider Monkey
Nov-30	Steady Q3 Growth and Shareholder Returns Reinforce Bentley Systems' (BSY) Outlook BSY Insider Monkey
Nov-30	Strong Analyst Confidence Keeps Via Transportation (VIA) on Track to Capture Its $82 Billion Market VIA Insider Monkey
Nov-30	CAR-Therapy Keeps Analyst Confidence in Arcellx (ACLX) High Ahead of the ASH Meeting ACLX Insider Monkey
Nov-30	Axon Enterprise's (AXON) Acquisition Strategy Drives Bullish Analyst Sentiment Despite Earnings Miss AXON Insider Monkey
Nov-30	Shares Fall, Yet Analysts See Opportunity in Oversold Varonis Systems (VRNS) VRNS Insider Monkey
Nov-30	Strong Operational Momentum and Market Expansions Maintains Bullish Sentiment on e.l.f. Beauty (ELF) ELF Insider Monkey
Nov-30	Strong Base44 Platform Momentum Drives Analyst Confidence in Wix.com (WIX) WIX Insider Monkey
Nov-30	Strong High-Performance AI Cloud Momentum Holds Investor Confidence in CoreWeave (CRWV) CRWV Insider Monkey
Nov-30	Zai Lab (ZLAB) Remains a Buy Amid Strong Commercial and Pipeline Momentum ZLAB Insider Monkey
Nov-30	Strategy's (MSTR) New Credit Rating Dashboard Launch Looks to Calm Investors Amid Crypto November Decline MSTR Insider Monkey
Nov-30	Bullish Analyst Sentiment on Elastic N.V. (ESTC) Holds Despite Softer Net-New Cloud Momentum ESTC Insider Monkey
Nov-29	Analyst Confidence Upbeat on Shattuck Labs (STTK) Amid SL-325 Progress and Earlier Q3 2025 Result STTK Insider Monkey
Nov-29	Analyst Confidence High in Erasca (ERAS) Amid Pipeline Advancement and Earlier Q3 2025 Results ERAS Insider Monkey
Nov-29	Gain Therapeutics' (GANX) Preclinical Momentum Drives Its Progress in Parkinson's Drug Development GANX Insider Monkey
Nov-29	Veritone's (VERI) Debt Discipline and AI Expansion Drive Its Evolving Growth Story VERI Insider Monkey
Nov-29	Analyst Confidence High in Bitfarms Ltd. (BITF) Following Q3 2025 Results BITF Insider Monkey
Nov-29	Analyst Confidence Strong in Annexon (ANNX) Amid Vonaprument Advancement ANNX Insider Monkey
Nov-29	Piper Sandler Initiates Coverage on Opus Genetics, Inc. (IRD) With "Overweight" Rating and $7 PT IRD Insider Monkey
Nov-29	Bullish Outlook on Zura Bio Limited (ZURA) Amid Tibulizumab Phase 2 Clinical Trial Progress ZURA Insider Monkey
Nov-29	H.C. Wainwright Initiates Coverage on Acrivon Therapeutics (ACRV) With "Buy" Rating and $19 PT ACRV Insider Monkey
Nov-29	Analyst Confidence in Orchestra BioMed Holdings (OBIO) High Amid Key Clinical and Strategic Advancements OBIO Insider Monkey
Nov-24	Goldman Sachs Remains Bullish on Devon Energy (DVN) Following Q3 2025 Results DVN Insider Monkey
Nov-24	Piper Sandler Reiterates "Buy" Rating on Expand Energy Corporation (EXE) With $138 PT EXE Insider Monkey
Nov-24	Morgan Stanley Remains Bullish on EQT Corporation (EQT) Following Strong Multi-Year Performance EQT Insider Monkey
Nov-24	Strong EPS Growth to Drive Linde plc (LIN) in 2026, Supports UBS Bullish Stance LIN Insider Monkey
Nov-24	Improved Uranium Pricing Supports Cameco Corporation (CCJ) Through Short-Term Production Headwinds; TD Securities Remains Bullish CCJ Insider Monkey
Nov-24	UBS Remains Bullish on ConocoPhillips (COP) Amid Cost Pressures and Softer 2026 Oil Volume Outlook COP Insider Monkey
Nov-24	Susquehanna Remains Bullish on Occidental Petroleum (OXY) Amid Strong Earnings and Production Momentum OXY Insider Monkey
Nov-24	Montney Expansion and NuVista Energy Acquisition to Support Ovintiv (OVV) Future Growth; Citi Remains Bullish OVV Insider Monkey
Nov-24	Goldman Sachs Remains Bullish on The Mosaic Company (MOS) Following Q3 2025 Results MOS Insider Monkey
Nov-24	Strong Cash Flow to Support EOG Resources' (EOG) Robust Pipeline Amid Oil Supply Headwinds; RBC Capital Remains Bullish EOG Insider Monkey
Nov-24	Evercore ISI Remains Bullish on Air Products and Chemicals (APD) Following Q4 2025 Results APD Insider Monkey
Nov-24	Piper Sandler Reduces PT on Range Resources Corporation (RRC) to $37 Following Q3 2025 Results RRC Insider Monkey
Nov-21	Hut 8 (HUT) Sells Its 310-Megawatt Portfolio of Four Natural Gas Plants HUT Insider Monkey
Nov-21	Canaccord Genuity Remains Bullish on IREN Limited (IREN) Following Q3 2025 Results IREN Insider Monkey
Nov-21	Mizuho Remains Bullish on Strategy (MSTR) Following Q3 2025 Results MSTR Insider Monkey
Nov-21	SoFi Technologies' (SOFI) SoFi Crypto Launch Makes It First Nationally Chartered, FDIC-Insured Bank in the U.S. SOFI Insider Monkey
Nov-21	William Blair's Jeffrey Reiterates "Buy" Rating on Block (XYZ) Following Q3 2025 Results XYZ Insider Monkey
Nov-21	Citizens Remains Bullish on Robinhood Markets (HOOD) Amid Leadership Changes HOOD Insider Monkey
Nov-21	Bernstein's Chhugani Remains Bullish on Coinbase Global (COIN) with $510 PT COIN Insider Monkey
Nov-17	Evercore Remains Bullish on Allegro MicroSystems (ALGM), Cites Robust Automotive and Data Center Cycles ALGM Insider Monkey
Nov-17	Riley Reduces Its Price Target on Bitdeer Technologies (BTDR) to $29, Maintains "Buy" Rating BTDR Insider Monkey
Nov-17	Goldman Sachs Maintains Neutral Stance on Alkami Technology (ALKT) Following Q3 2025 Results ALKT Insider Monkey
Nov-17	Goldman Sachs Remains Bullish on Vertex (VERX) After Q3 2025 Results VERX Insider Monkey
Nov-17	Synaptics (SYNA) Partners with Qualcomm to Advance Next-Generation Touch and Fingerprint Sensor Technologies SYNA Insider Monkey
Nov-17	Robert W. Baird Maintains "Buy" Rating on Commvault Systems (CVLT) With $215 PT CVLT Insider Monkey
Nov-17	BofA Remains Bullish on OneStream (OS), Cites Sustained Demand for Its AI-Powered Finance Solutions OS Insider Monkey
Nov-17	DA Davidson Raises PT on Q2 Holdings (QTWO) to $82, Maintains "Neutral" Rating QTWO Insider Monkey
Nov-17	Citi Maintains "Buy" Rating on Pagaya Technologies (PGY) With $40 PT PGY Insider Monkey
Nov-17	Barclays Sees "Potentially Huge Opportunity" for Impinj (PI), Cites Growing Momentum in Grocery Deployments PI Insider Monkey
Nov-16	RBC Capital Remains Bullish on Viridian Therapeutics (VRDN) Following Q3 2025 Results VRDN Insider Monkey
Nov-16	UroGen Pharma (URGN) Closes Q3 2025 With $127.4 Million in Cash Amid Rising R&D Costs URGN Insider Monkey
Nov-16	Raymond James Remains Bullish on Liquidia (LQDA), Cites YUTREPIA's 75% Growth in U.S. Prostacyclin Revenue LQDA Insider Monkey

Faheem Tahir

Recent Articles by Faheem Tahir

Upgrade your FINVIZ experience